Stay updated on Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The Record History page shows a new revision entry v3.3.2 and the removal of the previous revision v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-28T01:19:16.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.1 replacing the previous v3.2.0, indicating a backend/system update that does not change study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-20T22:12:13.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Removed the banner about government funding status from the page, which previously warned that updates may be delayed due to appropriations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-13T15:28:28.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The new screenshot shows updates to the record history with no substantive changes to the current trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-10-30T07:41:34.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    - Added a government funding notice about potential service disruptions and where to check status, plus a link to cc.nih.gov and opm.gov. - Updated version from v3.0.2 to v3.2.0.
    Difference
    12%
    Check dated 2025-10-08T20:20:10.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed; aside from that, no changes to core content, pricing, stock, or time slot availability.
    Difference
    0.7%
    Check dated 2025-09-16T00:29:27.000Z thumbnail image

Stay in the know with updates to Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.